This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (27) Citing Articles via Google Scholar Google Scholar Articles by Dhonneur, G. Articles by Merle, J. C. Search for Related Content PubMed PubMed Citation Articles by Dhonneur, G. Articles by Merle, J. C. Related Collections Pharmacology

---

ANESTHETIC PHARMACOLOGY

Skin Sensitivity to Rocuronium and Vecuronium: A Randomized Controlled Prick-Testing Study in Healthy Volunteers

Gilles Dhonneur, MD^*, Xavier Combes, MD^*, Didier Chassard, MD, and Jean Claude Merle, MD^* Section Editor

*Department of Anesthesia and Critical Care Medicine, University Hospital and Paris XII Val-de-Marne School of Medicine, Créteil, France; and Clinical Research Organisation, CEPHAC.ASTER Institut, Paris, France

Address correspondence and reprint requests to Dhonneur Gilles, MD, Département d’Anesthésie et de Réanimation, CHU Henri Mondor, 94000, Créteil CEDEX, France. Address e-mail to gilles.dhonneur{at}hmn.ap-hop-paris.fr

Prick tests are frequently used for the authentication of neuromuscular blocking drugs (NMBDs) as causative drugs for anaphylactic reactions during anesthesia. Unfortunately, the actual threshold concentration for skin testing remains debatable for most NMBDs. We studied the flare and wheal responses to prick tests with rocuronium and vecuronium. Thirty healthy, nonatopic, anesthesia-naive male and female volunteers (14 men and 16 women) from 18 to 40 yr of age were assigned randomly to receive a total of 10 prick tests—4 ascending dilutions (1:1000, 1:100, 1:10, and 1) of rocuronium and vecuronium and 2 controls—on both forearms. An assessor blinded to the assignment monitored systemic and skin responses to NMBDs and measured wheal and flare surfaces immediately after and 15 min after prick tests. None of the volunteers experienced any immediate systemic or cutaneous responses to rocuronium or vecuronium. Although a dilution of 1:1000 of both NMBDs failed to promote any skin response at 15 min, 50% and 40% of the subjects had a positive skin reaction to undiluted rocuronium and vecuronium, respectively. We demonstrated a sex effect related to smaller threshold concentration-induced cutaneous reactions in female volunteers to both muscle relaxants. Our observation questions the reliability of prick testing with undiluted solutions of rocuronium and vecuronium for the diagnosis of allergy.

IMPLICATIONS: Building concentration-skin response curves to prick tests with rocuronium and vecuronium in healthy, nonatopic, anesthesia-naive male and female volunteers demonstrated that the nonreactive concentration for both muscle relaxants is the 1:1000 dilution of the stock solutions. Our observation calls into question the past practice of prick-testing skin for sensitivity to neuromuscular blocking drugs by using undiluted solutions.

This article has been cited by other articles:

				P. Dewachter and C. Mouton-Faivre Skin Testing Performed in Individuals Cannot be Compared with Responses from Anaphylactic Patients Anesth. Analg., October 1, 2008; 107(4): 1441 - 1441. [Full Text] [PDF]

				J. H. Levy and N. F. Adkinson Jr Anaphylaxis During Cardiac Surgery: Implications for Clinicians Anesth. Analg., February 1, 2008; 106(2): 392 - 403. [Abstract] [Full Text] [PDF]

				M. Kroigaard, L. H. Garvey, T. Menne, and B. Husum Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing? Br. J. Anaesth., October 1, 2005; 95(4): 468 - 471. [Abstract] [Full Text] [PDF]

				S. M. Bhananker, J. T. O'Donnell, J. R. Salemi, and M. J. Bishop The Risk of Anaphylactic Reactions to Rocuronium in the United States Is Comparable to That of Vecuronium: An Analysis of Food and Drug Administration Reporting of Adverse Events Anesth. Analg., September 1, 2005; 101(3): 819 - 822. [Abstract] [Full Text] [PDF]

				P. M. Mertes, M. C. Laxenaire, J. M. Malinovsky, E. Florvaag, and D. A. Moneret-Vautrin Skin Sensitivity to Rocuronium and Vecuronium: Prick-Tests Are Not Intradermal Test Anesth. Analg., May 1, 2005; 100(5): 1539 - 1539. [Full Text] [PDF]

				G. Dhonneur Skin Sensitivity to Rocuronium and Vecuronium: Prick-Tests Are Not Intradermal Test Anesth. Analg., May 1, 2005; 100(5): 1539 - 1540. [Full Text] [PDF]

				M. Fisher and G. Dhonneur Prick Testing for Neuromuscular Blocking Drugs * Response Anesth. Analg., December 1, 2004; 99(6): 1880 - 1881. [Full Text] [PDF]

				J. H. Levy Anaphylactic Reactions to Neuromuscular Blocking Drugs: Are We Making the Correct Diagnosis? Anesth. Analg., April 1, 2004; 98(4): 881 - 882. [Full Text] [PDF]